Suven Life Sciences Limited
Overview
Suven Life Sciences Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic agents. They specialize in central nervous system (CNS) disorders such as Alzheimer's, schizophrenia, and depression.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Suven Life Sciences Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Suven Life Sciences Limited holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- LOSARTAN POTASSIUM USPActive2011-02-18
- ZOLMITRIPTANActive2009-10-20
- ARIPIPRAZOLEActive2009-06-01
- CALCIUM ACETATE USPActive2009-04-30
- DIVALPROEX SODIUMActive2006-03-18
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Suven Life Sciences Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Suven Life Sciences Limited? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.